Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 20% ± 5% |
Insufficient scRNA-seq data for expression of SLC10A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 7029.23 | 226 / 226 | 86% | 169.93 | 348 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.47 | 1 / 1 |
spleen | 98% | 18.04 | 235 / 241 | 0% | 0 | 0 / 0 |
ovary | 88% | 7.19 | 158 / 180 | 2% | 0.22 | 8 / 430 |
thymus | 90% | 7.32 | 585 / 653 | 0% | 0 | 0 / 605 |
intestine | 86% | 8.09 | 833 / 966 | 3% | 0.31 | 15 / 527 |
stomach | 85% | 6.29 | 306 / 359 | 3% | 0.10 | 10 / 286 |
lung | 86% | 6.87 | 498 / 578 | 3% | 0.13 | 29 / 1155 |
adrenal gland | 88% | 5.57 | 227 / 258 | 0% | 0 | 0 / 230 |
esophagus | 85% | 6.39 | 1230 / 1445 | 2% | 0.05 | 4 / 183 |
peripheral blood | 85% | 21.50 | 789 / 929 | 0% | 0 | 0 / 0 |
pancreas | 82% | 5.52 | 270 / 328 | 2% | 0.18 | 3 / 178 |
uterus | 81% | 6.30 | 138 / 170 | 1% | 0.03 | 5 / 459 |
prostate | 81% | 5.00 | 198 / 245 | 1% | 0.04 | 3 / 502 |
breast | 79% | 5.11 | 363 / 459 | 2% | 0.08 | 23 / 1118 |
bladder | 71% | 4.48 | 15 / 21 | 9% | 1.88 | 43 / 504 |
adipose | 78% | 6.18 | 943 / 1204 | 0% | 0 | 0 / 0 |
brain | 77% | 6.95 | 2043 / 2642 | 0% | 0.03 | 1 / 705 |
skin | 75% | 4.57 | 1349 / 1809 | 0% | 0.01 | 1 / 472 |
kidney | 73% | 4.01 | 65 / 89 | 2% | 0.19 | 15 / 901 |
blood vessel | 67% | 3.58 | 893 / 1335 | 0% | 0 | 0 / 0 |
heart | 66% | 3.67 | 570 / 861 | 0% | 0 | 0 / 0 |
muscle | 56% | 2.26 | 448 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0038183 | Biological process | bile acid signaling pathway |
GO_0031667 | Biological process | response to nutrient levels |
GO_0120188 | Biological process | regulation of bile acid secretion |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0006814 | Biological process | sodium ion transport |
GO_0043627 | Biological process | response to estrogen |
GO_0045471 | Biological process | response to ethanol |
GO_0055085 | Biological process | transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0008508 | Molecular function | bile acid:sodium symporter activity |
GO_0001618 | Molecular function | virus receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC10A1 |
Protein name | Na+-taurocholate cotransporting polypeptide Hepatic sodium/bile acid cotransporter (Cell growth-inhibiting gene 29 protein) (Na(+)/bile acid cotransporter) (Na(+)/taurocholate transport protein) (Sodium/taurocholate cotransporting polypeptide) (NTCP) (Solute carrier family 10 member 1) (SLC10A1) |
Synonyms | NTCP GIG29 |
Description | FUNCTION: As a major transporter of conjugated bile salts from plasma into the hepatocyte, it plays a key role in the enterohepatic circulation of bile salts necessary for the solubilization and absorption of dietary fat and fat-soluble vitamins . It is strictly dependent on the extracellular presence of sodium . It exhibits broad substrate specificity and transports various bile acids, such as taurocholate, cholate, as well as non-bile acid organic compounds, such as estrone sulfate . Works collaboratively with the ileal transporter (NTCP2), the organic solute transporter (OST), and the bile salt export pump (BSEP), to ensure efficacious biological recycling of bile acids during enterohepatic circulation . .; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis B virus. . |
Accessions | ENST00000216540.5 K7PFC0 Q14973 |